Unravelling genetic variants of a swedish family with high risk of prostate cancer
Abstract Background Prostate cancer is the most prevalent cancer in men worldwide. It is a polygenic disease with a substantial proportion of heritability. Identification of novel candidate biomarkers is crucial for clinical cancer prevention and the development of therapeutic strategies. Here, we d...
Main Authors: | Serena Barilla, Annika Lindblom, Hafdis T. Helgadottir |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13053-022-00234-0 |
Similar Items
-
Whole-Exome Sequencing of Germline Variants in Non-<i>BRCA</i> Families with Hereditary Breast Cancer
by: Yaxuan Liu, et al.
Published: (2022-04-01) -
Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer
by: Romy Mondschein, et al.
Published: (2022-07-01) -
Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications
by: Andreia Brandão, et al.
Published: (2020-07-01) -
A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome
by: Yanting Jiang, et al.
Published: (2019-06-01) -
Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management
by: David K. Doan, et al.
Published: (2021-04-01)